Keith A. Goldan
Chief Financial Officer at Syndax Pharmaceuticals · 8 reported transactions in 1 company · latest trade Feb 9, 2026
Their trades
Sold | Feb 9, 2026 | Feb 9, 2026 close $21.19 → Oct 29, 2026 close $14.15. S&P 500 +11.3% over the same days. | ||
Sold | Feb 6, 2026 | Feb 6, 2026 close $21.01 → Oct 29, 2026 close $14.15. S&P 500 +11.8% over the same days. | ||
Sold | Jul 16, 2025 | Jul 16, 2025 close $9.25 → Oct 29, 2026 close $14.15. S&P 500 +23.7% over the same days. |
$71.7K
Feb 9, 2026 close $21.19 → Oct 29, 2026 close $14.15. S&P 500 +11.3% over the same days.
$42.9K
Feb 6, 2026 close $21.01 → Oct 29, 2026 close $14.15. S&P 500 +11.8% over the same days.
$12K
Jul 16, 2025 close $9.25 → Oct 29, 2026 close $14.15. S&P 500 +23.7% over the same days.